Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             162 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities in resting-state EEG microstates are a vulnerability marker of migraine Li, Yansong

23 1 artikel
2 A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine Wu, Shouyi

23 1 artikel
3 Alterations in metabolic flux in migraine and the translational relevance Grech, Olivia

23 1 artikel
4 Alterations in pain processing circuitries in episodic migraine Mungoven, Tiffani J.

23 1 artikel
5 Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study Ren, Jing

23 1 artikel
6 Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study Yuan, Ziyu

23 1 artikel
7 Amplitude of low-frequency fluctuation after a single-trigger pain in patients with classical trigeminal neuralgia Ge, Xiuhong

23 1 artikel
8 A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study Yu, Shengyuan

23 1 artikel
9 Applying a biopsychosocial model to migraine: rationale and clinical implications Rosignoli, Chiara

23 1 artikel
10 A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States Krasenbaum, Lynda J.

23 1 artikel
11 Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2 Mozafarihashjin, Mohammad

23 1 artikel
12 Association between migraine and cognitive impairment Gu, Lihua

23 1 artikel
13 A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan Sakai, Fumihiko

23 1 artikel
14 A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine Khanal, Saval

23 1 artikel
15 Attenuated alpha oscillation and hyperresponsiveness reveals impaired perceptual learning in migraineurs Fong, Chun Yuen

23 1 artikel
16 Avoid or seek light – a randomized crossover fMRI study investigating opposing treatment strategies for photophobia in migraine Matt, Eva

23 1 artikel
17 Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities Pistoia, Francesca

23 1 artikel
18 Brain barriers and their potential role in migraine pathophysiology Wiggers, Astrid

23 1 artikel
19 Burden of tension-type headache in the Middle East and North Africa region, 1990-2019 Safiri, Saeid

23 1 artikel
20 Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model Tian, Ruimin

23 1 artikel
21 Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database Gérard, Alexandre O.

23 1 artikel
22 Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation Navarro-Pérez, María Pilar

23 1 artikel
23 Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients de Tommaso, Marina

23 1 artikel
24 Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study Fu, Tong

23 1 artikel
25 Cerebral perfusion variance in new daily persistent headache and chronic migraine: an arterial spin-labeled MR imaging study Bai, Xiaoyan

23 1 artikel
26 CGRP and PACAP-38 play an important role in diagnosing pediatric migraine Liu, Junhui

23 1 artikel
27 CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine Chou, Tse-Ming

23 1 artikel
28 CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury Ashina, Håkan

23 1 artikel
29 Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor Hage La Cour, Sanne

23 1 artikel
30 Comment regarding: what is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta‑analysis of clinical trials Han, Junhee

23 1 artikel
31 Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study Ornello, Raffaele

23 1 artikel
32 Contribution of tetrodotoxin-resistant persistent Na+ currents to the excitability of C-type dural afferent neurons in rats Nakamura, Michiko

23 1 artikel
33 Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications Rosignoli, Chiara

23 1 artikel
34 Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan Sakai, Fumihiko

23 1 artikel
35 Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-2019 Safiri, Saeid

23 1 artikel
36 Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies Nahas, Stephanie J.

23 1 artikel
37 Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) Barbanti, Piero

23 1 artikel
38 Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results Gantenbein, Andreas R.

23 1 artikel
39 Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients Ruscheweyh, Ruth

23 1 artikel
40 Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) Barbanti, Piero

23 1 artikel
41 Correction to: Hyperbaric oxygen attenuates neuropathic pain and reverses inflammatory signaling likely via the Kindlin-1/Wnt-10a signaling pathway in the chronic pain injury model in rats Zhao, Baisong

23 1 artikel
42 Correction to: Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists Krivoshein, G.

23 1 artikel
43 Cortical spreading depression can be triggered by sensory stimulation in primed wild type mouse brain: a mechanistic insight to migraine aura generation Hanalioglu, Sahin

23 1 artikel
44 Cortical spreading depression induces propagating activation of the thalamus ventral posteromedial nucleus in awake mice Fu, Xiaoxi

23 1 artikel
45 Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms Karsan, Nazia

23 1 artikel
46 Debate: Are cluster headache and migraine distinct headache disorders? Al-Karagholi, Mohammad Al-Mahdi

23 1 artikel
47 De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study Gallo, Daniel

23 1 artikel
48 Development and validation of a novel model for characterizing migraine outcomes within real-world data Hindiyeh, Nada A.

23 1 artikel
49 Diagnostic criteria for acute headache attributed to ischemic stroke and for sentinel headache before ischemic stroke Lebedeva, Elena R.

23 1 artikel
50 Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress Aczél, Timea

23 1 artikel
51 Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial De Icco, Roberto

23 1 artikel
52 Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine Zhang, Wei

23 1 artikel
53 Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release Christiansen, Isabella Mai

23 1 artikel
54 Dynamic brainstem and somatosensory cortical excitability during migraine cycles Hsiao, Fu-Jung

23 1 artikel
55 Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients Takeshima, Takao

23 1 artikel
56 Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine Buse, Dawn C.

23 1 artikel
57 Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials Cheng, Yu-Chen

23 1 artikel
58 Effects of a history of headache and migraine treatment on baseline neurocognitive function in young athletes McCarthy, Lily

23 1 artikel
59 Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study Barbanti, Piero

23 1 artikel
60 Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis Wang, Xing

23 1 artikel
61 Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation Lowe, Michael

23 1 artikel
62 Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model Liu, Tzu-Ting

23 1 artikel
63 Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients Gremeau-Richard, Christelle

23 1 artikel
64 Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study McAllister, Peter

23 1 artikel
65 Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study Ehrlich, Marc

23 1 artikel
66 European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure Sacco, Simona

23 1 artikel
67 European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update Sacco, Simona

23 1 artikel
68 Exploring alterations in sensory pathways in migraine Meylakh, Noemi

23 1 artikel
69 Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? Kopruszinski, Caroline M.

23 1 artikel
70 Expression of vasopressin and its receptors in migraine-related regions in CNS and the trigeminal system: influence of sex Maddahi, Aida

23 1 artikel
71 FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats Zhou, Yanjie

23 1 artikel
72 Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) Barbanti, Piero

23 1 artikel
73 Functional connectivity and structural changes of thalamic subregions in episodic migraine Yang, Ying

23 1 artikel
74 Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study Sobe, Hanna

23 1 artikel
75 Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials Lipton, Richard B.

23 1 artikel
76 Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience Silvestro, Marcello

23 1 artikel
77 Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study Hu, Bo

23 1 artikel
78 Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray with episodic and chronic migraine: a proton magnetic resonance spectroscopy study Wang, Wei

23 1 artikel
79 Genome-wide analyses identify novel risk loci for cluster headache in Han Chinese residing in Taiwan Chen, Shih-Pin

23 1 artikel
80 Genome-wide analysis identified novel susceptible genes of restless legs syndrome in migraineurs Jiang, Yun-Jin

23 1 artikel
81 Gradually shifting clinical phenomics in migraine spectrum: a cross-sectional, multicenter study of 5438 patients Ran, Ye

23 1 artikel
82 Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study Sampaio Rocha-Filho, Pedro Augusto

23 1 artikel
83 Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis Castaldo, Matteo

23 1 artikel
84 Headache-related circuits and high frequencies evaluated by EEG, MRI, PET as potential biomarkers to differentiate chronic and episodic migraine: Evidence from a systematic review Gomez-Pilar, Javier

23 1 artikel
85 HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain Du, Yu

23 1 artikel
86 Hypoperfusion in nucleus accumbens in chronic migraine using 3D pseudo-continuous arterial spin labeling imaging MRI Liu, Mengqi

23 1 artikel
87 IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine Chen, Hao

23 1 artikel
88 Imaging the inflammatory phenotype in migraine Christensen, Rune Häckert

23 1 artikel
89 Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies McAllister, Peter

23 1 artikel
90 Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study Hurh, Kyungduk

23 1 artikel
91 Insular functional connectivity in migraine with aura Gollion, Cédric

23 1 artikel
92 Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system Rosta, Judit

23 1 artikel
93 Interictal osmophobia is associated with longer migraine disease duration Gossrau, Gudrun

23 1 artikel
94 Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies Thuraiaiyah, Janu

23 1 artikel
95 Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors Edvinsson, Jacob C. A.

23 1 artikel
96 Long COVID headache Tana, Claudio

23 1 artikel
97 Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab Schwedt, Todd J.

23 1 artikel
98 Long term evaluation of a multidisciplinary trigeminal neuralgia service Singhota, Sanjeet

23 1 artikel
99 Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2 Apelian, Rami

23 1 artikel
100 Measuring interictal burden among people affected by migraine: a descriptive survey study Hubig, Lena T.

23 1 artikel
101 Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients Andersen, Anne Sofie Schott

23 1 artikel
102 Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting Peles, Ido

23 1 artikel
103 Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists Krivoshein, G.

23 1 artikel
104 Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition Vuralli, Doga

23 1 artikel
105 Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201) Johnston, Karissa

23 1 artikel
106 Narrative-based medicine in headache disorders Lampl, Christian

23 1 artikel
107 One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey Do, Thien Phu

23 1 artikel
108 Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study Cady, Roger

23 1 artikel
109 PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine Guo, Song

23 1 artikel
110 Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials Lipton, Richard B.

23 1 artikel
111 Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study Irimia, Pablo

23 1 artikel
112 Persistent headache after first-ever ischemic stroke: clinical characteristics and factors associated with its development Lebedeva, Elena R.

23 1 artikel
113 Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study Magdy, Rehab

23 1 artikel
114 Post-traumatic headache after mild traumatic brain injury in a one-year follow up study – risk factors and return to work Kraemer, Yvonn

23 1 artikel
115 Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine Greco, Rosaria

23 1 artikel
116 Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients Li, Ke

23 1 artikel
117 Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients Barbanti, Piero

23 1 artikel
118 Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency Eigenbrodt, Anna K.

23 1 artikel
119 Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study Crowe, Holly M.

23 1 artikel
120 Preventive treatment can reverse cognitive impairment in chronic migraine González-Mingot, Cristina

23 1 artikel
121 Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series Suwanwela, Nijasri C.

23 1 artikel
122 Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences Ashina, Håkan

23 1 artikel
123 P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine Wang, Yajuan

23 1 artikel
124 Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study Cowan, Robert P.

23 1 artikel
125 Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine Driessen, Maurice T.

23 1 artikel
126 Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study Driessen, Maurice T.

23 1 artikel
127 Real-World experience of interictal burden and treatment in migraine: a qualitative interview study Lo, Siu Hing

23 1 artikel
128 Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache Mo, Heejung

23 1 artikel
129 Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study Cullum, Christopher Kjaer

23 1 artikel
130 Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings Polavieja, Pepa

23 1 artikel
131 Repeated inflammatory dural stimulation-induced cephalic allodynia causes alteration of gut microbial composition in rats Miao, Shuai

23 1 artikel
132 Resting-state magnetoencephalographic oscillatory connectivity to identify patients with chronic migraine using machine learning Hsiao, Fu-Jung

23 1 artikel
133 Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience Raffaelli, Bianca

23 1 artikel
134 Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials Lampl, Christian

23 1 artikel
135 Serum CGRP in migraine patients using erenumab as preventive treatment de Vries Lentsch, Simone

23 1 artikel
136 Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China Zhang, Shuhua

23 1 artikel
137 Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis Lloyd, J.O.

23 1 artikel
138 Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model Pan, Qi

23 1 artikel
139 Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results Gantenbein, Andreas R.

23 1 artikel
140 Synaptic alterations in visual cortex reshape contrast-dependent gamma oscillations and inhibition-excitation ratio in a genetic mouse model of migraine Meneghetti, Nicolò

23 1 artikel
141 Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup Zhang, Leyi

23 1 artikel
142 The applicability research of the diagnostic criteria for 6.7.2 angiography headache in the international classification of headache disorders-3rd edition Lu, Chenglong

23 1 artikel
143 The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies Giri, Samita

23 1 artikel
144 The economic and personal burden of cluster headache: a controlled cross-sectional study Petersen, Anja Sofie

23 1 artikel
145 The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials Tao, Xinyu

23 1 artikel
146 The Global Campaign turns 18: a brief review of its activities and achievements Steiner, Timothy J.

23 1 artikel
147 The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates Stovner, Lars Jacob

23 1 artikel
148 The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients Ruscheweyh, Ruth

23 1 artikel
149 The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence Gollion, Cedric

23 1 artikel
150 The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study Kawatu, Nfwama

23 1 artikel
151 Time is of the essence in headache measurement. A response to Gil-Gouveia Steiner, TJ.

23 1 artikel
152 TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis” Gil-Gouveia, Raquel

23 1 artikel
153 Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury Ashina, Håkan

23 1 artikel
154 Tracking the evolution of non-headache symptoms through the migraine attack Messina, Roberta

23 1 artikel
155 Trends in utilization and costs of migraine medications, 2017–2020 Nguyen, Jennifer L.

23 1 artikel
156 Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia KC, Elina

23 1 artikel
157 Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study Schenk, Hannah

23 1 artikel
158 Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis Andreou, Anna P.

23 1 artikel
159 Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache Vandenbussche, Nicolas

23 1 artikel
160 Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure Tepper, Stewart J.

23 1 artikel
161 Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks Coppola, Gianluca

23 1 artikel
162 What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials Woldeamanuel, Yohannes W.

23 1 artikel
                             162 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland